Freya Gulamali

Freya Gulamali is a student at Duke University. She is working as an AAAS Mass Media Fellow at The News & Observer. Her research interests lie at the intersection of health policy and AI, and she has explored this as a data science researcher at the Duke Institute for Health Innovation and as a member of the Duke-Margolis Institute's scholars program. She is writing research stories for Health AI Partnership, to help health system leaders, researchers and clinicians stay updated on health AI.

Biography:  https://www.yahoo.com/news/news-observer-announces-2024-class-120000969.html

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

CDC Urges Updated COVID-19 and Flu Vaccines Amidst Rising Viral Activity and New Variants

CDC Urges Updated COVID-19 and Flu Vaccines Amidst Rising Viral Activity and New Variants

Broke On: Tuesday, 02 July 2024 The CDC urges most people to get updated COVID-19 and flu vaccines this fall, emphasizing the importance of staying protected against respiratory illnesses amidst new variants and an upcoming flu season. New COVID-19 vaccines target current strains and counteract waning protection from previous vaccinations.